Ascend Wellness Holdings AAWH
OTC AAWH
$0.43 +0.03 (+6.26%)
At close: Aug 19, 2026 · 3:11 PM UTC

Ascend Wellness Holdings (AAWH) Net Income towards Common Stockholders (2020 - 2026)

Ascend Wellness Holdings (AAWH) posted quarterly Net Income towards Common Stockholders of -$29.5 million for Q1 2026, down 53.15% year-over-year from -$62.9 million in Q1 2025, and up 39.44% quarter-over-quarter from -$48.7 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at -$29.5 million for Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders fell 53.15% year-over-year to -$29.5 million; the TTM figure through Mar 2026 stood at -$128.4 million (down 49.18% YoY), while the FY2025 annual figure was -$118.2 million, down 39.06% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$29.5 million, up from -$48.7 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $841000.0 in Q2 2023, with the low at -$48.7 million in Q4 2025.
  • The 5-year median for Net Income towards Common Stockholders is -$19.3 million (2023), against an average of -$21.3 million.
  • The sharpest annual moves came in 2023 and 2024: Net Income towards Common Stockholders jumped 103.97% in 2023, then tumbled 2690.25% in 2024.
  • Ascend Wellness Holdings' Net Income towards Common Stockholders stood at -$15.0 million in 2022, then decreased by 28.52% to -$19.3 million in 2023, then gained by 13.19% to -$16.8 million in 2024, then sank by 190.05% to -$48.7 million in 2025, then soared by 39.44% to -$29.5 million in 2026.
  • Business Quant data shows AAWH's Net Income towards Common Stockholders at -$29.5 million in Q1 2026, -$48.7 million in Q4 2025, and -$25.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn -576.00 Mn
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 866.00 Mn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 710.19 Mn
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn 333.00 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -118.80 Mn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn 144.40 Mn
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn 54.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Ascend Wellness Holdings 86.08 Mn 19.08 Mn 45.49 Mn -9.81 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.81 Mn
Mar 31, 2026 -29.49 Mn
Dec 31, 2025 -48.70 Mn
Sep 30, 2025 -25.83 Mn
Jun 30, 2025 -24.41 Mn
Mar 31, 2025 -19.26 Mn
Dec 31, 2024 -16.79 Mn
Sep 30, 2024 -28.26 Mn
Jun 30, 2024 -21.78 Mn
Mar 31, 2024 -18.16 Mn
Dec 31, 2023 -19.34 Mn
Sep 30, 2023 -11.24 Mn
Jun 30, 2023 841,000.00
Mar 31, 2023 -18.47 Mn
Dec 31, 2022 -15.05 Mn
Sep 30, 2022 -16.86 Mn
Jun 30, 2022 -21.17 Mn
Mar 31, 2022 -27.82 Mn
Dec 31, 2021 -16.51 Mn
Sep 30, 2021 -13.03 Mn